Skip Navigation



Carcinogenesis Advance Access published online on June 11, 2009

Carcinogenesis, doi:10.1093/carcin/bgp132
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
30/9/1581    most recent
bgp132v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cleveland, A. G.
Right arrow Articles by Gould, K. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cleveland, A. G.
Right arrow Articles by Gould, K. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Disruption of Estrogen Receptor Signaling Enhances Intestinal Neoplasia in ApcMin/+ Mice

Alicia G. Cleveland1,*, Seija I. Oikarinen2,*, Kimberly K. Bynoté1, Maija Marttinen2, Joseph J. Rafter3, Jan-Åke Gustafsson3, Shyamal K. Roy4, Henry C. Pitot5, Kenneth S. Korach6, Dennis B. Lubahn7,8,9,10, Marja Mutanen2 and Karen A. Gould1

1 Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA
2 Department of Applied Chemistry and Microbiology (Nutrition), P.O. Box 66, FIN-00014 University of Helsinki, Finland
3 Department of BioSciences and Nutrition, Karolinska Institute, NOVUM, S-14186 Huddinge, Sweden, and Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX 77204
4 Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
5 McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI 53706, USA
6 Receptor Biology Section, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, USA
7 Department of Biochemistry, University of Missouri, Columbia, MO, USA
8 Department of Child Health, University of Missouri, Columbia, MO, USA
9 Department of Animal Sciences, University of Missouri, Columbia, MO, USA
10 MU Center for Phytonutrient and Phytochemical Studies, University of Missouri, Columbia, MO, USA

Address correspondence to: Karen A. Gould: Phone: (402) 559-2456, Fax: (402) 559-7328, E-mail: kagould{at}unmc.edu

Estrogen Receptors {alpha} (ER{alpha} or ESR1) and β (ERβ or ESR2) are expressed in the human colon, but during the multistep process of colorectal carcinogenesis, expression of both ER{alpha} and ERβ is lost, suggesting that loss ER function might promote colorectal carcinogenesis. Through crosses between an ER{alpha} knockout and ApcMin mouse strains, we demonstrate that ER{alpha} deficiency is associated with a significant increase in intestinal tumor multiplicity, size and burden in ApcMin/+ mice. Within the normal intestinal epithelium of ApcMin/+ mice, ER{alpha} deficiency is associated with an accumulation of nuclear β-catenin, an indicator of activation of the Wnt-β-catenin signaling pathway, which is known to play a critical role in intestinal cancers. Consistent with the hypothesis that ER{alpha} deficiency is associated with activation of Wnt-β-catenin signaling, ER{alpha} deficiency in the intestinal epithelium of ApcMin/+ mice also correlated with increased expression of Wnt-β-catenin target genes. Through crosses between an ERβ knockout and ApcMin mouse strains, we observed some evidence that ERβ deficiency is associated with an increased incidence of colon tumors in ApcMin/+ mice. This effect of ERβ deficiency does not involve modulation of Wnt-β-catenin signaling. Our studies suggest that ER{alpha} and ERβ signaling modulate colorectal carcinogenesis, and ER{alpha} does so, at least in part, by regulating the activity of the Wnt-β-catenin pathway.

Key Words: estrogen receptor • tumorigenesis • intestine • Apc • colon


* These authors contributed equally to this work

Received November 6, 2008; revised April 30, 2009; accepted May 23, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.